Ushbu ish iqtibos qilgan ishlar
199 ta ish
Ish: Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?
In vivo CAR T cell generation to treat cancer and autoimmune disease
Theresa Hunter, Yanjie Bao, Yan Zhang +37
Maqola20253 iqtibosABITethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton, Harjeet Singh, Amer Najjar +12
MaqolaOchiq kirish20162 iqtibosABICombination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
Rachel Grosser, Leonid Cherkassky, Navin K. Chintala +1
Sharh maqolaOchiq kirish20192 iqtibosABIMesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
Gregory L. Beatty, Andrew R. Haas, Marcela V. Maus +9
MaqolaOchiq kirish20132 iqtibosABITumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
Hollie J. Pegram, James Lee, Erik Hayman +4
MaqolaOchiq kirish20122 iqtibosABIIL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors <i>in vivo</i>
Mythili Koneru, Terence J. Purdon, David R. Spriggs +2
MaqolaOchiq kirish20152 iqtibosABISupervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang +17
MaqolaOchiq kirish20092 iqtibosABIClonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal +33
MaqolaOchiq kirish20162 iqtibosABIThe role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer
Jennifer L. Hsu, Mien‐Chie Hung
Sharh maqolaOchiq kirish20162 iqtibosABITracking the Evolution of Non–Small-Cell Lung Cancer
Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan +80
MaqolaOchiq kirish20172 iqtibosABIBiomarker concordance between primary colorectal cancer and its metastases
Dilraj Bhullar, Jorge Barriuso, S. Mullamitha +3
Sharh maqolaOchiq kirish20192 iqtibosABIPD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Yongshuai Jiang, Ming Chen, Hong Nie +1
Sharh maqolaOchiq kirish20192 iqtibosABIMemory T cells: strategies for optimizing tumor immunotherapy
Qingjun Liu, Zhongjie Sun, Ligong Chen
Sharh maqolaOchiq kirish20202 iqtibosABIDeleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen +24
MaqolaOchiq kirish20212 iqtibosABIA genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapy
Lupeng Ye, Jonathan J. Park, Lei Peng +17
MaqolaOchiq kirish20222 iqtibosABI